BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31500591)

  • 1. LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma.
    Piao L; Yang Z; Feng Y; Zhang C; Cui C; Xuan Y
    BMC Cancer; 2019 Sep; 19(1):898. PubMed ID: 31500591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
    Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
    Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
    Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
    Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of leucine zipper/EF hand-containing transmembrane-1 overexpression in the prognosis of triple-negative breast cancer.
    Wang CA; Liu Q; Chen Y; Liu S; Xu J; Cui X; Zhang Y; Piao L
    Exp Mol Pathol; 2015 Apr; 98(2):254-9. PubMed ID: 25617527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
    Yang Z; Ni W; Cui C; Qi W; Piao L; Xuan Y
    Hum Pathol; 2018 Nov; 81():148-156. PubMed ID: 30031102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
    Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
    Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer.
    Piao L; Li H; Feng Y; Li X; Cui Y; Xuan Y
    Cancer Manag Res; 2020; 12():1649-1660. PubMed ID: 32184668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
    Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
    Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of lung tumorigenesis by leucine zipper/EF hand-containing transmembrane-1.
    Hwang SK; Piao L; Lim HT; Minai-Tehrani A; Yu KN; Ha YC; Chae CH; Lee KH; Beck GR; Park J; Cho MH
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
    Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
    Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of FATS in non-small cell lung cancer and its relationship with prognosis].
    Zhang TM; Zhang J; Zhou DJ; Wang CL
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):826-830. PubMed ID: 31770849
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
    Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
    Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
    Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
    Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPTF biomarker correlates with poor survival in human NSCLC.
    Gong YC; Liu DC; Li XP; Dai SP
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):102-107. PubMed ID: 28121349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.